Scientists track new Drug's journey through the body
NCT ID NCT07065617
Summary
This was an early, basic science study to understand how a new drug candidate, called BI 1819479, is absorbed, broken down, and eliminated by the body. It involved a small group of healthy male volunteers and used tiny amounts of a radioactive form of the drug to track its path. The goal was to gather foundational knowledge about how the drug behaves in people, which is a standard first step in drug development.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quotient Sciences
Nottingham, NG11 6JS, United Kingdom
Conditions
Explore the condition pages connected to this study.